Mackenzie Financial »

Amphastar Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $356k 5.8k 61.85
2023-09-30 $258k 5.8k 44.87

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Bank Of Montreal Cadcom (BMO)
Canadian Natl Ry (CNI)
Canadian Pacific Kansas City (CP)
Apple (AAPL)
Canadian Natural Resources (CNQ)
Telus Ord (TU)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Stantec (STN)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Accenture Plc Ireland Shs Class A (ACN)

View all positions for Mackenzie Financial

Top funds holding Amphastar Pharmaceuticals

Federated Investors
Vanguard Group
Neuberger Berman Group
Dimensional Fund Advisors
TD Asset Management
T. Rowe Price Associates
Boone Capital Management
Charles Schwab Investment Management
Oberweis Asset Management
Nordea Investment Management Ab
Bessemer
LSV Asset Management
Bank of New York Mellon
Mesirow Institutional Investment Management
Victory Capital Management

View all funds holding Amphastar Pharmaceuticals